Save time and get answers to complex questions with AI chat
Norcuron generic name?Guselkumab loss of exclusitivy?When will a generic version of xiaflex be available?What are the most memorable drug brands in oral factor b inhibitors? in united statesDrugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for ruxolitinib
The provided information does not include any clinical response-rate data for the ruxolitinib and azacitidine combination, so I can’t state a specific response rate from it.
“Response rate” can mean different endpoints in clinical trials, such as: - ORR (overall response rate) - CR (complete response) - CR/PL (complete response plus platelet recovery) - hematologic improvement or other composite response definitions If you tell me the exact study/trial (or the patient population, such as myelodysplastic syndromes, AML, or post-transplant relapse), I can align to the correct endpoint.
If you share the trial identifier (e.g., NCT number) or the text you’re working from, I can extract the reported response rate for ruxolitinib + azacitidine.
Other Questions About Ruxolitinib :